[go: up one dir, main page]

DE69930464D1 - Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung - Google Patents

Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung

Info

Publication number
DE69930464D1
DE69930464D1 DE69930464T DE69930464T DE69930464D1 DE 69930464 D1 DE69930464 D1 DE 69930464D1 DE 69930464 T DE69930464 T DE 69930464T DE 69930464 T DE69930464 T DE 69930464T DE 69930464 D1 DE69930464 D1 DE 69930464D1
Authority
DE
Germany
Prior art keywords
composition containing
oral administration
peptide material
during exercise
energy supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69930464T
Other languages
English (en)
Inventor
Loon Lucas Johannus Cornel Van
Antonius Johannus Wagenmakers
Andries Dirk Siemensma
Anthonie Kunst
Marcellinus Jacobus J Hakkaart
Wilhelmus Hermanus Maria Saris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kerry Group Services Ltd
Original Assignee
Kerry Group Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kerry Group Services Ltd filed Critical Kerry Group Services Ltd
Application granted granted Critical
Publication of DE69930464D1 publication Critical patent/DE69930464D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60Drinks from legumes, e.g. lupine drinks
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69930464T 1999-12-30 1999-12-30 Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung Expired - Lifetime DE69930464D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204607A EP1112693B1 (de) 1999-12-30 1999-12-30 Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung

Publications (1)

Publication Number Publication Date
DE69930464D1 true DE69930464D1 (de) 2006-05-11

Family

ID=8241130

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69930464T Expired - Lifetime DE69930464D1 (de) 1999-12-30 1999-12-30 Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung

Country Status (4)

Country Link
US (1) US6713082B2 (de)
EP (1) EP1112693B1 (de)
AT (1) ATE320724T1 (de)
DE (1) DE69930464D1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
MXPA02007466A (es) * 2000-02-01 2004-02-26 Muscletech Res And Dev Inc Suplemento alimenticio a base de acido alfa-lipoico para incrementar la masa muscular escas y la fuerza.
ATE383077T1 (de) * 2001-12-04 2008-01-15 Kerry Group Services Int Ltd Verfahren zur herstellung von belüfteten kohlenhydrathaltigen produkten
GB0207830D0 (en) * 2002-04-04 2002-05-15 Mars Uk Ltd Animal composition
US7338675B2 (en) * 2002-05-10 2008-03-04 Tsi Health Sciences, Inc. Fenugreek seed bio-active compositions and methods for extracting same
US20050176827A1 (en) * 2002-05-10 2005-08-11 Lee Steve S. Compositions and methods for glycogen synthesis
BR0312537A (pt) 2002-07-01 2005-04-19 Unilever Nv Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta
EP1534314B1 (de) * 2002-09-04 2014-10-22 DSM IP Assets B.V. Nutritionelle und therapeutische Zusammensetzung mit einem Insulin-Sensibilisator und einer Peptidfraktion
ATE349804T1 (de) 2002-09-06 2007-01-15 Ericsson Telefon Ab L M Zusammengesetzter leistungsverstärker
US7288570B2 (en) 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
EP1571925A1 (de) * 2002-12-20 2005-09-14 Unilever N.V. Zusammensetzungen zur regelung des blutglukosespiegels
US7850989B2 (en) * 2003-06-12 2010-12-14 Provimi North America, Inc. Critical care for neonatal calves
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
JP2005289861A (ja) * 2004-03-31 2005-10-20 Meiji Seika Kaisha Ltd グリコーゲンの貯蔵促進用の組成物
WO2007056176A2 (en) * 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions for preventing and reducing delayed onset muscle soreness
JP5645360B2 (ja) * 2006-04-21 2014-12-24 株式会社明治 ジペプチドを有効成分として含有する組成物
US20070280997A1 (en) * 2006-05-31 2007-12-06 Pacifichealth Laboratories, Inc. Composition for enhancing muscle recovery
GB0617182D0 (en) * 2006-08-31 2006-10-11 Glaxo Group Ltd Novel use
AU2007341981A1 (en) * 2006-12-29 2008-07-10 The Salk Institute For Biological Studies Methods for enhancing exercise performance
WO2008082577A2 (en) * 2006-12-30 2008-07-10 The Coca-Cola Company A composition comprising saccharides and peptides and uses thereof
EP1969950A1 (de) * 2007-03-12 2008-09-17 Cargill, Incorporated Teilweise hydrolysiertes Getreideprotein
FR2938733A1 (fr) * 2008-11-21 2010-05-28 Holymark Composition administrable par voie orale,en particulier pour personne pratiquant une activite physique et complement alimentaire renfermant une telle composition
JP5710506B2 (ja) * 2009-03-02 2015-04-30 ロケット フレールRoquette Freres 植物性ミルク造粒粉末、植物性ミルクを生産するための方法、およびその使用
CA2760325A1 (en) 2009-04-29 2010-11-04 Ganeden Biotech, Inc. Dead bacillus coagulans bacteria and uses thereof for boosting the immune system
EP2327316B1 (de) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Verfahren zur steigerung der muskelproteinsynthese
WO2012027285A1 (en) 2010-08-24 2012-03-01 Abbott Laboratories Nutritional products having improved organoleptic properties
WO2012135499A1 (en) * 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
BR112015020977A2 (pt) 2013-03-08 2017-07-18 Axiom Foods Inc suplemento de proteína de arroz e métodos de uso do mesmo
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
EP3634155A4 (de) 2017-05-12 2021-02-17 Axiom Foods Inc. Reisprodukte sowie systeme und verfahren zu deren herstellung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3080234A (en) * 1960-12-06 1963-03-05 Pfizer & Co C Method of improving the efficiency of amino acid diets
US4042688A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of providing high-protein nutrition by the oral administration of a predigested protein composition
JPH0647547B2 (ja) * 1985-03-20 1994-06-22 大塚製薬株式会社 栄養補給飲食品
FI904074A7 (fi) * 1989-08-28 1991-03-01 Milupa Ag Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
ES2063882T5 (es) * 1989-10-02 2001-12-01 Novartis Nutrition Ag Hidrolizados de proteinas.
LU88371A1 (fr) * 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Acides aminés essentiels renforcés
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US20020037830A1 (en) * 1996-04-18 2002-03-28 Jorn Havskov Berthelsen Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementation and an energy supplement containing such an additive
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise

Also Published As

Publication number Publication date
US6713082B2 (en) 2004-03-30
ATE320724T1 (de) 2006-04-15
US20010031729A1 (en) 2001-10-18
EP1112693A1 (de) 2001-07-04
EP1112693B1 (de) 2006-03-22

Similar Documents

Publication Publication Date Title
DE69930464D1 (de) Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung
AU2003273967A8 (en) Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
WO2004093650A3 (en) Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
DE69928226D1 (de) Chemokin rezeptor antagonisten und verwndung
KR880007514A (ko) 키놀린 화합물
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
EA200000693A1 (ru) Антагонисты хемокинного рецептора и способы их применения
CN1060178C (zh) 新的结构改性的活性肠肽衍生物、其药物组合物及其治疗男性阳痿的应用
CA2018791A1 (en) Hair treatment composition
ES2036661T3 (es) Un metodo para preparar una preparacion farmaceutica de pie de atleta.
US5378823A (en) Nucleic acids encoding type I interferon variants
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви
WO2001009119A3 (en) Chemokine receptor antagonists
MY146601A (en) Chemokine receptor antagonists and methods of use therefor
RU93000004A (ru) Вещество для лечения подкожной фибрасаркомы и способ его получения
EP1491192A4 (de) Die biologische wirkung fördernde zusammensetzungen mit isoflavon-agklykon aus sojabohnenkeimen
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
KR920003977A (ko) 신장질환치료제
Lamkin et al. Purification and Partial Characterization of a M r 52,000 Glycoprotein from Human Cancer Ascites Fluid Which Stimulates Bone Resorption in Vitro
ATE417061T1 (de) Scorpionpeptid als blutdrucksenkendes mittel
RU2002125545A (ru) Способ лечения псориаза
RU93016862A (ru) Водно-глицериновый комплекс (2,3-диоксипропил)-орто-титана-хлорид
Weinstock et al. Incentive value of saccharin as a function of concentration and deprivation conditions
RU2002112882A (ru) Способ повышения резистентности сухостойных коров

Legal Events

Date Code Title Description
8332 No legal effect for de